Cetirizine dihydrochloridum

Readily available Recent EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 10 mg Tablets

Type:

- Generics
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics

Therapeutic target:

- Allergy

Action: Anti-histamics H1 (Allergo)

Full Description:
Cetirizine dihydrochloridum dossier:
-New readily available for licensing
-Marketing Authorization obtained in The Netherlands, on-going in Belgium (we can also register in other countries)
-Stability: 25°C: 30 months, 40°C: 6 months

Availability and Market information:

Status: Registered (MA obtained)

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Netherlands : 1999
- Belgium : 2001
Registration info: Obtained in The Netherlands, on-going in Belgium
On request: registration in other countries
BE available

Market information

Other Market Info:

Patent Information:
Name: Zyrtec
Patent expiration date: 2002
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.